{"id":"insulin-delivery","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipohypertrophy"}]},"_chembl":null,"_dailymed":{"setId":"30610026-4fa7-45a1-96a5-41e9e1a278eb","title":"V-GO DISPOSABLE INSULIN DELIVERY DEVICE () [VALERITAS, INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This appears to be a delivery technology or device platform developed by Medical University of Graz for improved insulin administration in diabetes management. Without more specific information about the particular formulation, device type, or novel mechanism, the exact mechanistic details cannot be precisely characterized. Insulin delivery systems typically aim to improve glycemic control, patient compliance, or reduce injection burden.","oneSentence":"Insulin delivery refers to a system or technology platform for administering insulin to patients, rather than a specific molecular drug.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T05:09:34.987Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus requiring insulin therapy"}]},"trialDetails":[{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT07293715","phase":"PHASE4","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-25","conditions":"Pregnancy, High Risk, Type 1 Diabetes","enrollment":44},{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT06948760","phase":"NA","title":"Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D","status":"COMPLETED","sponsor":"Mark D. DeBoer, MD, MSc., MCR","startDate":"2025-07-23","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT07423637","phase":"NA","title":"The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-04-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT07478211","phase":"","title":"Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery","status":"RECRUITING","sponsor":"Lia Bally","startDate":"2025-05-09","conditions":"Diabetes Mellitus, Type 1, Energy Metabolism","enrollment":40},{"nctId":"NCT07212179","phase":"NA","title":"Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery","status":"RECRUITING","sponsor":"Anas El Fathi","startDate":"2026-03-03","conditions":"Type 1 Diabetes","enrollment":6},{"nctId":"NCT06579404","phase":"NA","title":"Closed-loop in Adults With Type 2 Diabetes","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2024-12-06","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":224},{"nctId":"NCT07468188","phase":"NA","title":"Diabetes Body Project 2","status":"RECRUITING","sponsor":"Joslin Diabetes Center","startDate":"2025-01-24","conditions":"Eating Disorders, Type 2 Diabetes","enrollment":42},{"nctId":"NCT05418699","phase":"","title":"Real-life Data From Diabetic Patients on Closed-loop Pumps","status":"COMPLETED","sponsor":"Groupe Hospitalier de la Rochelle Ré Aunis","startDate":"2022-09-26","conditions":"Type 1 Diabetes","enrollment":410},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT07463417","phase":"NA","title":"Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women","status":"COMPLETED","sponsor":"Sarah Wragge Wellness","startDate":"2024-04-01","conditions":"Metabolic Syndrome, Obesity & Overweight, Blood Glucose Monitoring","enrollment":85},{"nctId":"NCT05799781","phase":"NA","title":"Two Way Crossover Closed Loop MPC vs Control IQ","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2023-03-13","conditions":"Type 1 Diabetes","enrollment":29},{"nctId":"NCT02088658","phase":"NA","title":"Technology Intensified Diabetes Education Study in African Americans","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2013-05","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent","enrollment":200},{"nctId":"NCT07455643","phase":"NA","title":"Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts","status":"COMPLETED","sponsor":"University of Catania","startDate":"2025-04-20","conditions":"Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT06597149","phase":"NA","title":"Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels","status":"RECRUITING","sponsor":"Indiana University","startDate":"2025-04-16","conditions":"Healthy","enrollment":30},{"nctId":"NCT05626725","phase":"","title":"Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2022-12-01","conditions":"Type 1 Diabetes","enrollment":76},{"nctId":"NCT05821322","phase":"NA","title":"Blood Glucose Target Before and During Exercise in Adults With Type 1 Diabetes Using an Artificial Pancreas","status":"TERMINATED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2023-07-01","conditions":"Type 1 Diabetes","enrollment":6},{"nctId":"NCT06422325","phase":"NA","title":"Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-07-12","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT07325461","phase":"NA","title":"Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2026-02-18","conditions":"Diabetes Mellitus, Type 1","enrollment":20},{"nctId":"NCT00743782","phase":"PHASE2","title":"Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2008-08-22","conditions":"Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1","enrollment":21},{"nctId":"NCT06325202","phase":"NA","title":"Closed Loop and Education for Hypoglycemia Awareness Restoration","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2025-10-03","conditions":"Diabetes Mellitus, Type 1","enrollment":324},{"nctId":"NCT07039981","phase":"NA","title":"Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insulet Corporation","startDate":"2025-07-01","conditions":"Diabetes Mellitus","enrollment":48},{"nctId":"NCT07427251","phase":"PHASE4","title":"The Postprandial Hypo-Avoid Study","status":"NOT_YET_RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2026-03-15","conditions":"Type 1 Diabetes Mellitus","enrollment":18},{"nctId":"NCT07186660","phase":"PHASE2","title":"Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2026-02-22","conditions":"Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus, Insulin","enrollment":40},{"nctId":"NCT07427134","phase":"NA","title":"Pediatric Insulin Plan Calculator for T1DM Management","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-03-01","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM), T1DM","enrollment":440},{"nctId":"NCT07430293","phase":"NA","title":"Hybrid Closed-Loop Insulin Delivery After Pancreatectomy","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2026-03-01","conditions":"Pancreatectomy, Total Pancreatectomy, Partial Pancreatectomy","enrollment":24},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT03905941","phase":"EARLY_PHASE1","title":"Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-08-23","conditions":"Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT07425912","phase":"","title":"Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2025-09-05","conditions":"Type 1 Diabetes Mellitus","enrollment":76},{"nctId":"NCT07422532","phase":"NA","title":"A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis","status":"NOT_YET_RECRUITING","sponsor":"Imperial College London","startDate":"2026-04-01","conditions":"Type 2 Diabetes, Chronic Kidney Disease 5D","enrollment":84},{"nctId":"NCT05562492","phase":"NA","title":"Closed-loop for People Living With Cystic Fibrosis Related Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2023-04-12","conditions":"Cystic Fibrosis-related Diabetes","enrollment":128},{"nctId":"NCT07226583","phase":"NA","title":"Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-04","conditions":"Type 1 Diabetes Mellitis, Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus (T1DM)","enrollment":20},{"nctId":"NCT05785832","phase":"NA","title":"A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2023-06-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":319},{"nctId":"NCT07420972","phase":"NA","title":"Pilot Study of Intrapartum Insulin Pump","status":"NOT_YET_RECRUITING","sponsor":"Medstar Health Research Institute","startDate":"2026-04","conditions":"Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2), Pregnancy","enrollment":30},{"nctId":"NCT07287943","phase":"NA","title":"To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.","status":"RECRUITING","sponsor":"Viral N. Shah","startDate":"2026-02-09","conditions":"Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I","enrollment":34},{"nctId":"NCT06024928","phase":"NA","title":"Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2024-06-18","conditions":"Type 2 Diabetes","enrollment":23},{"nctId":"NCT07087340","phase":"NA","title":"Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis","status":"RECRUITING","sponsor":"University of Bern","startDate":"2026-01-21","conditions":"Type-1-Diabetes","enrollment":6},{"nctId":"NCT06453928","phase":"NA","title":"Starting Technology in At Risk Type 1 Diabetes Study","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2024-09-05","conditions":"Diabetes Mellitus, Type 1","enrollment":40},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT06925217","phase":"NA","title":"Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes","status":"RECRUITING","sponsor":"Heba Al-Alwan","startDate":"2025-06-16","conditions":"Type 2 Diabetes, Chronic Kidney Disease Stage 3","enrollment":76},{"nctId":"NCT07401901","phase":"NA","title":"Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2026-07-15","conditions":"Type 1 Diabetes (T1D)","enrollment":230},{"nctId":"NCT05744856","phase":"NA","title":"A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam","status":"COMPLETED","sponsor":"Thai Binh University of Medicine and Pharmacy","startDate":"2023-01-16","conditions":"GDM","enrollment":435},{"nctId":"NCT07226128","phase":"NA","title":"The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2026-02-15","conditions":"HIV, Depression in Adults, Insulin Resistance","enrollment":150},{"nctId":"NCT06834568","phase":"NA","title":"Tandem Freedom - Feasibility Trial 2","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2025-03-24","conditions":"Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT06883344","phase":"NA","title":"Automated Insulin for Management of Intrapartum Glycemia","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-12-05","conditions":"Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes","enrollment":150},{"nctId":"NCT07379944","phase":"NA","title":"Guided Visualization Meditation for Reducing Surgical Stress Response in Cardiac Surgery Patients","status":"NOT_YET_RECRUITING","sponsor":"University of Gaziantep","startDate":"2026-01-15","conditions":"Cardiac Surgery, Surgical Stress Response, Coronary Artery Disease","enrollment":72},{"nctId":"NCT07070830","phase":"NA","title":"Simplified Onboarding in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Insulet Corporation","startDate":"2025-07-18","conditions":"Type 2 Diabetes Mellitus","enrollment":56},{"nctId":"NCT07276776","phase":"NA","title":"An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insulet Corporation","startDate":"2025-12-12","conditions":"Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT07376850","phase":"NA","title":"Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Motol","startDate":"2026-01","conditions":"Diabetes, Diabetes (DM), Diabetes Type 1","enrollment":120},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT07015970","phase":"","title":"Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop","status":"COMPLETED","sponsor":"ISIS Diabete Service","startDate":"2024-03-05","conditions":"Diabetes Mellitus Type 1, Glucose Metabolism Disorder, Glycemic Control for Diabetes Mellitus","enrollment":87},{"nctId":"NCT06630585","phase":"PHASE3","title":"GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-02-14","conditions":"Type 1 Diabetes (T1D)","enrollment":42},{"nctId":"NCT07265245","phase":"NA","title":"Evaluating an Analogy-Based Consultation Approach for Insulin-Treated Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Ministry of Health, Malaysia","startDate":"2023-01-01","conditions":"Type 2 Diabetes","enrollment":106},{"nctId":"NCT06547918","phase":"NA","title":"SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes","status":"COMPLETED","sponsor":"Insulet Corporation","startDate":"2024-07-18","conditions":"Diabetes Mellitus","enrollment":48},{"nctId":"NCT07356986","phase":"","title":"Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-01","conditions":"Gestational Diabetes, Postpartum","enrollment":50},{"nctId":"NCT07356089","phase":"","title":"Twiist Postmarket Surveillance Study for Type 1 Diabetes","status":"RECRUITING","sponsor":"Deka Research and Development","startDate":"2025-12-09","conditions":"Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus","enrollment":1875},{"nctId":"NCT07011147","phase":"NA","title":"Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Type 1 Diabetes (T1D), Type 2 Diabetes, Diabetes, Autoimmune","enrollment":240},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT07353086","phase":"NA","title":"Evaluation of Horizontal Mandibular Ridge Augmentation Through Subperiosteal Tunneling by Using Bovine Sticky Bone (Radio-Histological Study)","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-08-25","conditions":"Posterior Mandible With Deficient Ridge Width","enrollment":10},{"nctId":"NCT07341373","phase":"PHASE1","title":"A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500","status":"RECRUITING","sponsor":"Portal Diabetes, Inc.","startDate":"2026-01","conditions":"Type 1 Diabetes","enrollment":25},{"nctId":"NCT07348432","phase":"","title":"The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"McGill University","startDate":"2024-07-29","conditions":"Insulin Dependent Diabetes Mellitus, Feeding and Eating Disorders, Eating Behavior","enrollment":106},{"nctId":"NCT07155668","phase":"PHASE3","title":"A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Viridian Therapeutics, Inc.","startDate":"2025-07-01","conditions":"Thyroid Eye Disease","enrollment":87},{"nctId":"NCT07240012","phase":"NA","title":"Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-12-01","conditions":"Diabete Type 1, Pregnancy Complications","enrollment":305},{"nctId":"NCT06127823","phase":"NA","title":"Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-01-03","conditions":"GDM, Gestational Diabetes, Nutritional and Metabolic Diseases","enrollment":214},{"nctId":"NCT03818178","phase":"NA","title":"Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-12-01","conditions":"Insulin Resistance","enrollment":60},{"nctId":"NCT06463483","phase":"NA","title":"Automated Insulin Delivery in Adults With Advanced Kidney Disease","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-11-01","conditions":"Chronic Kidney Diseases, Diabetes Mellitus","enrollment":12},{"nctId":"NCT05000021","phase":"NA","title":"Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2022-06-27","conditions":"Type 1 Diabetes","enrollment":93},{"nctId":"NCT06730906","phase":"NA","title":"PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-01-10","conditions":"Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT03999853","phase":"PHASE1, PHASE2","title":"Butyrate Adjuvant Therapy for Type 1 Diabetes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-07-28","conditions":"Type1diabetes","enrollment":6},{"nctId":"NCT03253263","phase":"PHASE2","title":"A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants","status":"RECRUITING","sponsor":"OHB Neonatology Ltd.","startDate":"2019-05-09","conditions":"Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage","enrollment":338},{"nctId":"NCT07251257","phase":"","title":"The Seafarers' Continuous Glucose Monitoring Systems Study","status":"RECRUITING","sponsor":"University of Surrey","startDate":"2025-11-20","conditions":"Insulin Dependent Diabetes","enrollment":50},{"nctId":"NCT07318740","phase":"NA","title":"Effectiveness of Mobile Application-Supported Education and Counseling in Pregnant Women With Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-08-18","conditions":"Gestational Diabetes Mellitus (GDM)","enrollment":94},{"nctId":"NCT07320495","phase":"NA","title":"Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2025-06-19","conditions":"Diabetes Mellitus Type 1","enrollment":200},{"nctId":"NCT07317856","phase":"NA","title":"Efficacy of Microneedling With Hyaluronic Acid Injection for Gingival Augmentation in Thin Gingival Phenotype","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01","conditions":"Thin Gingival Biotype","enrollment":20},{"nctId":"NCT07317102","phase":"","title":"Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)","status":"NOT_YET_RECRUITING","sponsor":"Insulet Corporation","startDate":"2026-02","conditions":"Diabetes, Type 1 Diabetes, Diabetes Mellitus","enrollment":152},{"nctId":"NCT06853990","phase":"NA","title":"Innovative Automated Insulin Delivery System for Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Deka Research and Development","startDate":"2025-04-14","conditions":"Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus","enrollment":300},{"nctId":"NCT03875755","phase":"NA","title":"Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-04","conditions":"Gestational Diabetes Mellitus","enrollment":1080},{"nctId":"NCT06082973","phase":"NA","title":"Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge","status":"COMPLETED","sponsor":"Universitat Politècnica de València","startDate":"2024-05-15","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT06048757","phase":"NA","title":"Mobile Application-delivered Resistance Program for Children and Adolescents With Type 1 Diabetes (Diactive-1)","status":"COMPLETED","sponsor":"Fundacion Miguel Servet","startDate":"2023-08-20","conditions":"Type 1 Diabetes","enrollment":62},{"nctId":"NCT07284511","phase":"PHASE2, PHASE3","title":"A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar","status":"NOT_YET_RECRUITING","sponsor":"Melissa-Rosina Pasqua","startDate":"2026-01-05","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D","enrollment":105},{"nctId":"NCT04510506","phase":"NA","title":"Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-11-19","conditions":"Type 1 Diabetes","enrollment":42},{"nctId":"NCT06645834","phase":"NA","title":"Smart MDI Study (CIP343)","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2024-12-06","conditions":"Diabetes Mellitus, Type 1","enrollment":179},{"nctId":"NCT07039942","phase":"","title":"French Prospective Multicentric Study in Real World","status":"RECRUITING","sponsor":"Insulet Corporation","startDate":"2025-07-23","conditions":"Diabetes, Diabetes Mellitus, Type 1 Diabetes","enrollment":304},{"nctId":"NCT07263802","phase":"NA","title":"Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism","status":"NOT_YET_RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2025-12-01","conditions":"Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (Prediabetes)","enrollment":90},{"nctId":"NCT07154251","phase":"NA","title":"Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2025-11-06","conditions":"Type 1 Diabetes (T1D)","enrollment":16},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT06488469","phase":"NA","title":"Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-07-01","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT05389514","phase":"","title":"Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Providence Health & Services","startDate":"","conditions":"KRAS G12V Mutant Advanced Epithelial Cancers","enrollment":""},{"nctId":"NCT00597480","phase":"PHASE4","title":"Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-01","conditions":"Small for Gestational Age","enrollment":10},{"nctId":"NCT06646107","phase":"","title":"Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference","status":"RECRUITING","sponsor":"Attikon Hospital","startDate":"2025-03-01","conditions":"Type1diabetes","enrollment":240},{"nctId":"NCT06428591","phase":"NA","title":"Tandem Freedom Feasibility Study 1","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2024-05-29","conditions":"Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT07231341","phase":"","title":"Insulin Resistance in Gestational Diabetes Mellitus","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2022-09-22","conditions":"Gestational Diabetes Mellitus (GDM)","enrollment":100},{"nctId":"NCT06418880","phase":"PHASE3","title":"Automated Insulin Delivery for Inpatients With Dysglycemia","status":"COMPLETED","sponsor":"Emory University","startDate":"2025-01-22","conditions":"Type 1 Diabetes, Type 2 Diabetes","enrollment":130},{"nctId":"NCT04945369","phase":"NA","title":"Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled \"EPIPOD\".","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2022-02-02","conditions":"Preterm Children","enrollment":114},{"nctId":"NCT04419779","phase":"NA","title":"Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes","status":"SUSPENDED","sponsor":"Fractyl Health Inc.","startDate":"2021-03-08","conditions":"Type 2 Diabetes","enrollment":320},{"nctId":"NCT07227805","phase":"NA","title":"Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)","status":"NOT_YET_RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2026-06-15","conditions":"Diabetes (Insulin-requiring, Type 1 or Type 2)","enrollment":116},{"nctId":"NCT05120544","phase":"NA","title":"Expanding Technology-Enabled Nurse Delivered Chronic Disease Care","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-04-21","conditions":"Diabetes Mellitus, Type 2, Hypertension","enrollment":220},{"nctId":"NCT06717451","phase":"","title":"PS230005 Control-IQ 1.5 Post-Approval Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2025-01-30","conditions":"Type 1 Diabetes","enrollment":144},{"nctId":"NCT05893797","phase":"NA","title":"A Study of LY8888AX in Participants Using a Connected Insulin Management Platform","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-10-05","conditions":"Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4428,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"insulin delivery","genericName":"insulin delivery","companyName":"Medical University of Graz","companyId":"medical-university-of-graz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin delivery refers to a system or technology platform for administering insulin to patients, rather than a specific molecular drug. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus requiring insulin therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}